Koki Matsumoto, Dini Kurnia Ikliptikawati, Kei Makiyama, Kako Mochizuki, Maho Tobita, Isao Kobayashi, Dominic Chih-Cheng Voon, Keesiang Lim, Kazuma Ogawa, Ikuo Kashiwakura, Hiroshi I Suzuki, Hironori Yoshino, Richard W Wong, Masaharu Hazawa
{"title":"相分离的超级增强子赋予基因组 DNA 先天的抗辐射能力。","authors":"Koki Matsumoto, Dini Kurnia Ikliptikawati, Kei Makiyama, Kako Mochizuki, Maho Tobita, Isao Kobayashi, Dominic Chih-Cheng Voon, Keesiang Lim, Kazuma Ogawa, Ikuo Kashiwakura, Hiroshi I Suzuki, Hironori Yoshino, Richard W Wong, Masaharu Hazawa","doi":"10.1093/jrr/rrae044","DOIUrl":null,"url":null,"abstract":"<p><p>Recently, biomolecular condensates formed through liquid-liquid phase separation have been widely reported to regulate key intracellular processes involved in cell biology and pathogenesis. BRD4 is a nuclear protein instrumental to the establishment of phase-separated super-enhancers (SEs) to direct the transcription of important genes. We previously observed that protein droplets of BRD4 became hydrophobic as their size increase, implying an ability of SEs to limit the ionization of water molecules by irradiation. Here, we aim to establish if SEs confer radiation resistance in cancer cells. We established an in vitro DNA damage assay that measures the effect of radicals provoked by the Fenton reaction on DNA integrity. This revealed that DNA damage was markedly reduced when BRD4 underwent phase separation with DNA. Accordingly, co-focal imaging analyses revealed that SE foci and DNA damage foci are mutually exclusive in irradiated cells. Lastly, we observed that the radioresistance of cancer cells was significantly reduced when irradiation was combined with ARV-771, a BRD4 de-stabilizer. Our data revealed the existence of innately radioresistant genomic regions driven by phase separation in cancer cells. The disruption of these phase-separated components enfolding genomic DNA may represent a novel strategy to augment the effects of radiotherapy.</p>","PeriodicalId":16922,"journal":{"name":"Journal of Radiation Research","volume":" ","pages":"482-490"},"PeriodicalIF":1.9000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11262858/pdf/","citationCount":"0","resultStr":"{\"title\":\"Phase-separated super-enhancers confer an innate radioresistance on genomic DNA.\",\"authors\":\"Koki Matsumoto, Dini Kurnia Ikliptikawati, Kei Makiyama, Kako Mochizuki, Maho Tobita, Isao Kobayashi, Dominic Chih-Cheng Voon, Keesiang Lim, Kazuma Ogawa, Ikuo Kashiwakura, Hiroshi I Suzuki, Hironori Yoshino, Richard W Wong, Masaharu Hazawa\",\"doi\":\"10.1093/jrr/rrae044\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Recently, biomolecular condensates formed through liquid-liquid phase separation have been widely reported to regulate key intracellular processes involved in cell biology and pathogenesis. BRD4 is a nuclear protein instrumental to the establishment of phase-separated super-enhancers (SEs) to direct the transcription of important genes. We previously observed that protein droplets of BRD4 became hydrophobic as their size increase, implying an ability of SEs to limit the ionization of water molecules by irradiation. Here, we aim to establish if SEs confer radiation resistance in cancer cells. We established an in vitro DNA damage assay that measures the effect of radicals provoked by the Fenton reaction on DNA integrity. This revealed that DNA damage was markedly reduced when BRD4 underwent phase separation with DNA. Accordingly, co-focal imaging analyses revealed that SE foci and DNA damage foci are mutually exclusive in irradiated cells. Lastly, we observed that the radioresistance of cancer cells was significantly reduced when irradiation was combined with ARV-771, a BRD4 de-stabilizer. Our data revealed the existence of innately radioresistant genomic regions driven by phase separation in cancer cells. The disruption of these phase-separated components enfolding genomic DNA may represent a novel strategy to augment the effects of radiotherapy.</p>\",\"PeriodicalId\":16922,\"journal\":{\"name\":\"Journal of Radiation Research\",\"volume\":\" \",\"pages\":\"482-490\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11262858/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Radiation Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/jrr/rrae044\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Radiation Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jrr/rrae044","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
最近,通过液-液相分离形成的生物分子凝聚物被广泛报道用于调控细胞生物学和致病机理中的关键细胞内过程。BRD4 是一种核蛋白,有助于建立相分离的超级增强子(SE),从而引导重要基因的转录。我们以前曾观察到,BRD4的蛋白液滴随着体积的增大而疏水,这意味着SEs有能力限制辐照对水分子的电离。在这里,我们的目的是确定 SE 是否会赋予癌细胞抗辐射能力。我们建立了一种体外 DNA 损伤检测方法,用于测量芬顿反应引发的自由基对 DNA 完整性的影响。结果显示,当BRD4与DNA发生相分离时,DNA损伤明显减少。因此,共焦成像分析表明,在辐照细胞中,SE灶和DNA损伤灶是相互排斥的。最后,我们观察到,当辐照与 BRD4 去稳定剂 ARV-771 结合使用时,癌细胞的放射抗性显著降低。我们的数据揭示了癌细胞中存在由相分离驱动的先天抗放射基因组区域。破坏这些包围基因组DNA的相分离成分可能是增强放疗效果的一种新策略。
Phase-separated super-enhancers confer an innate radioresistance on genomic DNA.
Recently, biomolecular condensates formed through liquid-liquid phase separation have been widely reported to regulate key intracellular processes involved in cell biology and pathogenesis. BRD4 is a nuclear protein instrumental to the establishment of phase-separated super-enhancers (SEs) to direct the transcription of important genes. We previously observed that protein droplets of BRD4 became hydrophobic as their size increase, implying an ability of SEs to limit the ionization of water molecules by irradiation. Here, we aim to establish if SEs confer radiation resistance in cancer cells. We established an in vitro DNA damage assay that measures the effect of radicals provoked by the Fenton reaction on DNA integrity. This revealed that DNA damage was markedly reduced when BRD4 underwent phase separation with DNA. Accordingly, co-focal imaging analyses revealed that SE foci and DNA damage foci are mutually exclusive in irradiated cells. Lastly, we observed that the radioresistance of cancer cells was significantly reduced when irradiation was combined with ARV-771, a BRD4 de-stabilizer. Our data revealed the existence of innately radioresistant genomic regions driven by phase separation in cancer cells. The disruption of these phase-separated components enfolding genomic DNA may represent a novel strategy to augment the effects of radiotherapy.
期刊介绍:
The Journal of Radiation Research (JRR) is an official journal of The Japanese Radiation Research Society (JRRS), and the Japanese Society for Radiation Oncology (JASTRO).
Since its launch in 1960 as the official journal of the JRRS, the journal has published scientific articles in radiation science in biology, chemistry, physics, epidemiology, and environmental sciences. JRR broadened its scope to include oncology in 2009, when JASTRO partnered with the JRRS to publish the journal.
Articles considered fall into two broad categories:
Oncology & Medicine - including all aspects of research with patients that impacts on the treatment of cancer using radiation. Papers which cover related radiation therapies, radiation dosimetry, and those describing the basis for treatment methods including techniques, are also welcomed. Clinical case reports are not acceptable.
Radiation Research - basic science studies of radiation effects on livings in the area of physics, chemistry, biology, epidemiology and environmental sciences.
Please be advised that JRR does not accept any papers of pure physics or chemistry.
The journal is bimonthly, and is edited and published by the JRR Editorial Committee.